
Please try another search
Full Alliance Group, Inc. is a diverse public holding company, which acquires assets in the healthcare, nutraceuticals and cardiovascular healing space. The Company’s subsidiary includes EBO2, Inc. EBO2, Inc. is the provider of EBO2, a blood treatment technology. EBO2 is a high-volume blood gas exchange unit for the treatment of 5-7 liters of blood with medical ozone, the unit allows extracorporeal blood and oxygenation and ozone exposure and blood filtration by using the integrated diffusing membranes within the filter fibers to trap lipids and proteins, which are in excess in the venous blood supply. EBO2 treatments and Nutra Yu nutraceutical products provide relief in cardiovascular disease, anxiety and depression, autoimmune and inflammatory conditions, mold-related issues, nutritional deficiencies, general health and wellness, Lyme disease, gut health and digestive issues, cancer support, hormonal imbalances, chronic pain, and other.
Name | Age | Since | Title |
---|---|---|---|
Henry Tacsan Ruiz | - | 2018 | Director |
David Martinez | - | 2018 | Director |
Paul Brian Volpp | - | 2019 | CEO, President & Director |
Rudy Kiste | - | 2019 | CFO & Director |
Marilyn Ball | - | - | VP, Secretary & Director |
Paula Monahan | - | - | Director |
George Johnsen | - | - | Director |
Michael Brausen | - | - | Director |
Robert Masterson | - | 2013 | Director of Operations & Executive Director |
Robert Alexander | 77 | 2000 | Director |
Richard M. Goldfarb | 69 | 2023 | Member of Medical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review